Medicine for treating hepatitis B

Abstract

The invention discloses a medicine for treating hepatitis B. The medicine is prepared from the following raw materials in parts by weight: 15-25 parts of raw radix astragalis, 10-15 parts of endothelium corneum gigeriae galli, 10-15 parts of polygonum cuspidatum, 10-15 parts of salvia miltiorrhiza, 10-15 parts of dried rehamnnia root, 4-6 parts of lucid ganoderma, 10-15 parts of Chinese wolfberry fruits, 5-10 parts of rhizoma picrorhizae, 3-6 parts of pseudo-ginseng, 4-6 parts of ligusticum wallichii, 8-12 parts of radix rehmanniae praeparata, 5-10 parts of roasted semen raphani, 10-15 parts of phyllanthus emblica, 13-18 parts of gynostemma pentaphylla, 10-15 parts of phyllanthus urinaria, 3-5 parts of polygonum cuspidatum, 5-7 parts of sculellaria barbata, 1-3 parts of pogostemon cablin, 13-18 parts of radix paeoniae alba, 3-5 parts of rotala rotundifolia, 1-3 parts of hypericum and 2-4 parts of sambucus chinensis root. The medicine is simple and reasonable in combination, has the effects of clearing heat, removing toxicity, relieving adverse qi, warming yang, tonifying liver and the like, and has durable effect, symptom and root cause treatment, firm curative effect and no relapse. Long-time clinical verification proves that the HBsAg negative conversion ratio is 70 percent, and the clinical effective rate is 92 percent.

Description

technical field [0001] The invention relates to a medicine for treating hepatitis B, which belongs to the field of traditional Chinese medicines. Background technique [0002] Chronic hepatitis B (referred to as hepatitis B) refers to those who are positive for hepatitis B virus, and the course of the disease is more than half a year or the date of onset is not clear, and the clinical manifestations of chronic hepatitis are clinically manifested; the clinical manifestations are fatigue, fear of eating, nausea, abdominal distension, pain in the liver area and other symptoms. This disease belongs to the category of "yellow bile" in traditional Chinese medicine; so far, among the dozens of anti-hepatitis B drugs that have been marketed, none of them can completely cure hepatitis B disease; Western medicine or traditional Chinese medicine is mostly used in the treatment of hepatitis B disease in the prior art. None of these medicines has very obvious curative effects; especially...

AI Technical Summary

Problems solved by technology

This disease belongs to the category of "yellow bile" in traditional Chinese medicine; so far, among the dozens of anti-hepatitis B drugs that have been marketed, none of them can completely cure hepatitis B disease; Western medicine or traditional Chinese medicine is mostly used in the treatment of hepatitis B disease in the prior art. None of these medicines has very obvious curative effects; especially western medicines such as: lamivudine, adefovir dipivoxil, entecavir and tenofovir, in the process of use, the virus is very easy to develop drug resistance, and once taken orally, it cannot be stopped. Otherwise, it will rebound; at the same time, the price is expensive, the side effects are large, and the liver and kidney functions are greatly damaged.